Literature DB >> 11790830

Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin.

Martin Linhult1, Hans Kaspar Binz, Mathias Uhlén, Sophia Hober.   

Abstract

Streptococcal protein G (SpG) is a bacterial cell surface receptor exhibiting affinity to both human immunoglobulin (IgG) and human serum albumin (HSA). Interestingly, the serum albumin and immunoglobulin-binding activities have been shown to reside at functionally and structurally separated receptor domains. The binding domain of the HSA-binding part has been shown to be a 46-residue triple alpha-helical structure, but the binding site to HSA has not yet been determined. Here, we have investigated the precise binding region of this bacterial receptor by protein engineering applying an alanine-scanning procedure followed by binding studies by surface plasmon resonance (SPR). The secondary structure as well as the HSA binding of the resulting albumin-binding domain (ABD) variants were analyzed using circular dichroism (CD) and affinity blotting. The analysis shows that the HSA binding involves residues mainly in the second alpha-helix.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790830      PMCID: PMC2373446          DOI: 10.1110/ps.02802

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  30 in total

1.  Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges.

Authors:  S Albeck; R Unger; G Schreiber
Journal:  J Mol Biol       Date:  2000-05-05       Impact factor: 5.469

2.  Structural response to mutation at a protein-protein interface.

Authors:  C K Vaughan; A M Buckle; A R Fersht
Journal:  J Mol Biol       Date:  1999-03-12       Impact factor: 5.469

3.  Biophysical characterization of the interaction of the beta-lactamase TEM-1 with its protein inhibitor BLIP.

Authors:  S Albeck; G Schreiber
Journal:  Biochemistry       Date:  1999-01-05       Impact factor: 3.162

4.  Solution structure of the albumin-binding GA module: a versatile bacterial protein domain.

Authors:  M U Johansson; M de Château; M Wikström; S Forsén; T Drakenberg; L Björck
Journal:  J Mol Biol       Date:  1997-03-14       Impact factor: 5.469

5.  Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity.

Authors:  T Clackson; M H Ultsch; J A Wells; A M de Vos
Journal:  J Mol Biol       Date:  1998-04-17       Impact factor: 5.469

6.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.

Authors:  S Curry; H Mandelkow; P Brick; N Franks
Journal:  Nat Struct Biol       Date:  1998-09

Review 7.  The use of gene fusions to protein A and protein G in immunology and biotechnology.

Authors:  S Ståhl; P A Nygren
Journal:  Pathol Biol (Paris)       Date:  1997-01

8.  The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

Authors:  C Libon; N Corvaïa; J F Haeuw; T N Nguyen; S Ståhl; J Y Bonnefoy; C Andreoni
Journal:  Vaccine       Date:  1999-02-05       Impact factor: 3.641

9.  Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis.

Authors:  H Gårdsvoll; K Danø; M Ploug
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

10.  Analysis of protein-protein interactions by mutagenesis: direct versus indirect effects.

Authors:  D E Otzen; A R Fersht
Journal:  Protein Eng       Date:  1999-01
View more
  14 in total

1.  Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.

Authors:  Cynthia A Davies-Venn; Bonnie Angermiller; Nathaniel Wilganowski; Pradip Ghosh; Barrett R Harvey; Grace Wu; Sunkuk Kwon; Melissa B Aldrich; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

Review 2.  Derivatization with fatty acids in peptide and protein drug discovery.

Authors:  Peter Kurtzhals; Søren Østergaard; Erica Nishimura; Thomas Kjeldsen
Journal:  Nat Rev Drug Discov       Date:  2022-08-24       Impact factor: 112.288

3.  Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives.

Authors:  Roland Stork; Emmanuelle Campigna; Bruno Robert; Dafne Müller; Roland E Kontermann
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

4.  Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3.

Authors:  Johan Nilvebrant; Mikael Astrand; John Löfblom; Sophia Hober
Journal:  Cell Mol Life Sci       Date:  2013-06-02       Impact factor: 9.261

5.  Orthogonal protein purification facilitated by a small bispecific affinity tag.

Authors:  Johan Nilvebrant; Tove Alm; Sophia Hober
Journal:  J Vis Exp       Date:  2012-01-16       Impact factor: 1.355

6.  Engineering bispecificity into a single albumin-binding domain.

Authors:  Johan Nilvebrant; Tove Alm; Sophia Hober; John Löfblom
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 7.  The albumin-binding domain as a scaffold for protein engineering.

Authors:  Johan Nilvebrant; Sophia Hober
Journal:  Comput Struct Biotechnol J       Date:  2013-09-01       Impact factor: 7.271

8.  Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action.

Authors:  Odile E Levy; Carolyn M Jodka; Shijun Steven Ren; Lala Mamedova; Abhinandini Sharma; Manoj Samant; Lawrence J D'Souza; Christopher J Soares; Diane R Yuskin; Li Jenny Jin; David G Parkes; Krystyna Tatarkiewicz; Soumitra S Ghosh
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

9.  Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.

Authors:  Liliane Goetsch; Jean Francois Haeuw; Thierry Champion; Christine Lacheny; Thien N'Guyen; Alain Beck; Nathalie Corvaia
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain.

Authors:  Yongsheng Liu; Anzhelika Vorobyeva; Tianqi Xu; Anna Orlova; Annika Loftenius; Theresa Bengtsson; Per Jonasson; Vladimir Tolmachev; Fredrik Y Frejd
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.